415 related articles for article (PubMed ID: 26193259)
1. Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes.
Sand LG; Szuhai K; Hogendoorn PC
Int J Mol Sci; 2015 Jul; 16(7):16176-215. PubMed ID: 26193259
[TBL] [Abstract][Full Text] [Related]
2. [Functional genomics of Ewing sarcoma].
Grünewald TGP
Pathologe; 2017 Nov; 38(Suppl 2):198-201. PubMed ID: 28849372
[TBL] [Abstract][Full Text] [Related]
3. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.
Kovar H
Expert Opin Ther Targets; 2014 Nov; 18(11):1315-28. PubMed ID: 25162919
[TBL] [Abstract][Full Text] [Related]
4. Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report.
Arnold MA; Ballester LY; Pack SD; Abdullaev Z; Merchant M; Tsokos MG
Pediatr Dev Pathol; 2014; 17(4):302-7. PubMed ID: 24735198
[TBL] [Abstract][Full Text] [Related]
5. A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma.
Sugita S; Arai Y; Tonooka A; Hama N; Totoki Y; Fujii T; Aoyama T; Asanuma H; Tsukahara T; Kaya M; Shibata T; Hasegawa T
Am J Surg Pathol; 2014 Nov; 38(11):1571-6. PubMed ID: 25007147
[TBL] [Abstract][Full Text] [Related]
6. Ewing sarcoma: biology-based therapeutic perspectives.
Potratz J; Jürgens H; Craft A; Dirksen U
Pediatr Hematol Oncol; 2012 Feb; 29(1):12-27. PubMed ID: 22304007
[TBL] [Abstract][Full Text] [Related]
7. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
Grünewald TG; Bernard V; Gilardi-Hebenstreit P; Raynal V; Surdez D; Aynaud MM; Mirabeau O; Cidre-Aranaz F; Tirode F; Zaidi S; Perot G; Jonker AH; Lucchesi C; Le Deley MC; Oberlin O; Marec-Bérard P; Véron AS; Reynaud S; Lapouble E; Boeva V; Rio Frio T; Alonso J; Bhatia S; Pierron G; Cancel-Tassin G; Cussenot O; Cox DG; Morton LM; Machiela MJ; Chanock SJ; Charnay P; Delattre O
Nat Genet; 2015 Sep; 47(9):1073-8. PubMed ID: 26214589
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.
Theisen ER; Pishas KI; Saund RS; Lessnick SL
Oncotarget; 2016 Apr; 7(14):17616-30. PubMed ID: 26848860
[TBL] [Abstract][Full Text] [Related]
9. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
Warren M; Weindel M; Ringrose J; Venable C; Reyes A; Terashima K; Rao P; Chintagumpala M; Hicks MJ; Lopez-Terrada D; Lu XY
Hum Pathol; 2013 Oct; 44(10):2010-9. PubMed ID: 23706910
[TBL] [Abstract][Full Text] [Related]
10. The genomic breakpoint and chimeric transcripts in the EWSR1-ETV4/E1AF gene fusion in Ewing sarcoma.
Ishida S; Yoshida K; Kaneko Y; Tanaka Y; Sasaki Y; Urano F; Umezawa A; Hata J; Fujinaga K
Cytogenet Cell Genet; 1998; 82(3-4):278-83. PubMed ID: 9858836
[TBL] [Abstract][Full Text] [Related]
11. Next steps in preventing Ewing sarcoma progression.
Knott MM; Dallmayer M; Grünewald TG
Future Oncol; 2016 Jan; 12(1):1-4. PubMed ID: 26615856
[No Abstract] [Full Text] [Related]
12. Precision medicine in Ewing sarcoma: a translational point of view.
Gargallo P; Juan A; Yáñez Y; Dolz S; Segura V; Castel V; Cañete A
Clin Transl Oncol; 2020 Sep; 22(9):1440-1454. PubMed ID: 32026343
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Novel
Boone MA; Taslim C; Crow JC; Selich-Anderson J; Watson M; Heppner P; Hamill J; Wood AC; Lessnick SL; Winstanley M
Mol Cancer Res; 2021 Nov; 19(11):1795-1801. PubMed ID: 34465585
[TBL] [Abstract][Full Text] [Related]
14. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
15. Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy.
Salet MC; Vogels R; Brons P; Schreuder B; Flucke U
Diagn Pathol; 2016 Aug; 11(1):74. PubMed ID: 27506465
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Analysis in Ewing Sarcoma.
Simon JM; Gomez NC
Methods Mol Biol; 2021; 2226():285-302. PubMed ID: 33326110
[TBL] [Abstract][Full Text] [Related]
17. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
[TBL] [Abstract][Full Text] [Related]
18. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
[TBL] [Abstract][Full Text] [Related]
19. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies.
Knott MML; Hölting TLB; Ohmura S; Kirchner T; Cidre-Aranaz F; Grünewald TGP
Cancer Metastasis Rev; 2019 Dec; 38(4):625-642. PubMed ID: 31970591
[TBL] [Abstract][Full Text] [Related]
20. High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma.
Lynn M; Wang Y; Slater J; Shah N; Conroy J; Ennis S; Morris T; Betts DR; Fletcher JA; O'Sullivan MJ
Diagn Mol Pathol; 2013 Jun; 22(2):76-84. PubMed ID: 23628818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
